[Drug-clinics. The hue and cry over central appetite suppressants!].
Scheen
A J
AJ
Département de Médecine, Université de Liège.
D018663:Adrenergic Agents / Q000009:adverse effects / Q000627:therapeutic use; D000328:Adult; D000662:Amphetamines / Q000009:adverse effects / Q000627:therapeutic use; D001066:Appetite / Q000187:drug effects; D001067:Appetite Depressants / Q000009:adverse effects / Q000627:therapeutic use*; D005260:Female; D005277:Fenfluramine / Q000009:adverse effects / Q000627:therapeutic use; D006349:Heart Valve Diseases / Q000139:chemically induced; D006801:Humans; D006976:Hypertension, Pulmonary / Q000139:chemically induced; D009765:Obesity / Q000188:drug therapy; D010645:Phentermine / Q000009:adverse effects / Q000627:therapeutic use; D018490:Serotonin Agents / Q000009:adverse effects / Q000627:therapeutic use
D018663:Adrenergic Agents; D000662:Amphetamines; D001067:Appetite Depressants; D018490:Serotonin Agents; D005277:Fenfluramine; D010645:Phentermine